JVI Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Komagome, R.
Right arrow Articles by Nagashima, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Komagome, R.
Right arrow Articles by Nagashima, K.

 Previous Article  |  Next Article 

Journal of Virology, December 2002, p. 12992-13000, Vol. 76, No. 24
0022-538X/02/$04.00+0     DOI: 10.1128/JVI.76.24.12992-13000.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Oligosaccharides as Receptors for JC Virus

Rika Komagome,1 Hirofumi Sawa,1* Takashi Suzuki,2 Yasuo Suzuki,2 Shinya Tanaka,1 Walter J. Atwood,3 and Kazuo Nagashima1

Laboratory of Molecular and Cellular Pathology, School of Medicine, Hokkaido University, CREST, JST, Sapporo 060-8638,1 Department of Biochemistry, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka 422-8526, Japan,2 Department of Molecular Microbiology and Immunology, Brown University, Providence, Rhode Island 029123

Received 7 June 2002/ Accepted 11 September 2002

JC virus (JCV) belongs to the polyomavirus family of double-stranded DNA viruses and in humans causes a demyelinating disease of the central nervous system, progressive multifocal leukoencephalopathy. Its hemagglutination activity and entry into host cells have been reported to depend on an N-linked glycoprotein containing sialic acid. In order to identify the receptors of JCV, we generated virus-like particles (VLP) consisting of major viral capsid protein VP1. We then developed an indirect VLP overlay assay to detect VLP binding to glycoproteins and a panel of glycolipids. We found that VLP bound to sialoglycoproteins, including {alpha}1-acid glycoprotein, fetuin, and transferrin receptor, and that this binding depended on {alpha}2-3-linked sialic acids and N-linked sugar chains. Neoglycoproteins were synthesized by using ovalbumin and conjugation with oligosaccharides containing the terminal {alpha}2-3- or {alpha}2-6-linked sialic acid or the branched {alpha}2-6-linked sialic acid. We show that the neoglycoprotein containing the terminal {alpha}2-6-linked sialic acid had the highest affinity for VLP, inhibited the hemagglutination activity of VLP and JCV, and inhibited the attachment of VLP to cells. We also demonstrate that VLP bound to specific glycolipids, such as lactosylceramide, and gangliosides, including GM3, GD2, GD3, GD1b, GT1b, and GQ1b, and that VLP bound weakly to GD1a but did not bind to GM1a, GM2, or galactocerebroside. Furthermore, the neoglycoprotein containing the terminal {alpha}2-6-linked sialic acid and the ganglioside GT1b inhibited JCV infection in the susceptible cell line IMR-32. These results suggest that the oligosaccharides of glycoproteins and glycolipids work as JCV receptors and may be feasible as anti-JCV agents.


* Corresponding author. Mailing address: Laboratory of Molecular and Cellular Pathology, School of Medicine, Hokkaido University, N15, W7, Kita-ku, Sapporo 060-8638, Japan. Phone: 81-11-706-5053. Fax: 81-11-706-7806. E-mail: h-sawa{at}patho2.med.hokudai.ac.jp.


Journal of Virology, December 2002, p. 12992-13000, Vol. 76, No. 24
0022-538X/02/$04.00+0     DOI: 10.1128/JVI.76.24.12992-13000.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. Mol. Cell. Biol. Microbiol. Mol. Biol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2002 by the American Society for Microbiology. All rights reserved.